9
IRUS TotalDownloads
Altmetric
β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0021925821011819-main.pdf | Published version | 1.69 MB | Adobe PDF | View/Open |
Title: | β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins. |
Authors: | Ninkina, N Millership, SJ Peters, OM Connor-Robson, N Chaprov, K Kopylov, AT Montoya, A Kramer, H Withers, DJ Buchman, VL |
Item Type: | Journal Article |
Abstract: | Synucleins, a family of three proteins highly expressed in neurons, are predominantly known for the direct involvement of α-synuclein in the aetiology and pathogenesis of Parkinson's and certain other neurodegenerative diseases, but their precise physiological functions are still not fully understood. Previous studies have demonstrated the importance of α-synuclein as a modulator of various mechanisms implicated in chemical neurotransmission, but information concerning the involvement of other synuclein family members, β-synuclein and γ-synuclein, in molecular processes within presynaptic terminals is limited. Here we demonstrated that the vesicular monoamine transporter 2 (VMAT2)-dependent dopamine uptake by synaptic vesicles isolated from the striatum of mice lacking β-synuclein is significantly reduced. Reciprocally, reintroduction, either in vivo or in vitro, of β-synuclein but not α- or γ-synuclein improves uptake by triple α/β/γ-synuclein deficient striatal vesicles. We also showed that the resistance of dopaminergic neurons of the substantia nigra pars compacta (SNpc) to subchronic administration of the Parkinson's disease-inducing prodrug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) depends on the presence of β-synuclein but only when one or both other synucleins are absent. Furthermore, proteomic analysis of synuclein-deficient synaptic vesicles vs those containing only β-synuclein revealed differences in their protein compositions. We suggest that the observed potentiation of dopamine uptake by β-synuclein might be caused by different protein architecture of the synaptic vesicles. It is also feasible that such structural changes improve synaptic vesicle sequestration of 1-methyl-4-phenylpyridinium (MPP+), a toxic metabolite of MPTP, which would explain why dopaminergic neurons expressing β-synuclein and lacking α-synuclein and/or γ-synuclein are resistant to this neurotoxin. |
Issue Date: | Dec-2021 |
Date of Acceptance: | 28-Oct-2021 |
URI: | http://hdl.handle.net/10044/1/92795 |
DOI: | 10.1016/j.jbc.2021.101375 |
ISSN: | 0021-9258 |
Publisher: | American Society for Biochemistry and Molecular Biology |
Start Page: | 1 |
End Page: | 15 |
Journal / Book Title: | Journal of Biological Chemistry |
Volume: | 297 |
Issue: | 6 |
Copyright Statement: | © 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Sponsor/Funder: | Wellcome Trust ISSF Funding Medical Research Council |
Funder's Grant Number: | 204834/Z/16/Z MC-A654-5QB40 |
Keywords: | MPTP toxicity Parkinson’s disease Synuclein dopamine dopaminergic neurons neurodegenerative disease neurotransmitter vesicular uptake synapse transgenic mice vesicles MPTP toxicity Parkinson’s disease Synuclein dopamine dopaminergic neurons neurodegenerative disease neurotransmitter vesicular uptake synapse transgenic mice vesicles 03 Chemical Sciences 06 Biological Sciences 11 Medical and Health Sciences Biochemistry & Molecular Biology |
Publication Status: | Published |
Conference Place: | United States |
Online Publication Date: | 2021-11-02 |
Appears in Collections: | Department of Metabolism, Digestion and Reproduction Institute of Clinical Sciences |
This item is licensed under a Creative Commons License